Stereotaxis, Inc.
For the period ended Sep 30, 2025. Filed Nov 12, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 12, 2025
STXS$1.03-9.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Convertible Preferred Stock and Stockholders’ Equity
Three Months Ended September 30, 2024
| (in thousands, except share amounts) · Convertible Preferred Stock Series A (Mezzanine) · Common Stock · Additional Paid-In Capital · Treasury Stock · Accumulated Deficit · Total Stockholders’ Equity (Deficit) | ||||||||
|---|---|---|---|---|---|---|---|---|
| Shares | Amount | Shares | Amount | Amount | Amount | Amount | Amount | |
| Balance at June 30, 2024 | 21,683 | $5,408 | 82,990,159 | $83 | $559,499 | $(206) | $(548,020) | $11,356 |
| Stock issued for the exercise of stock options | - | 53,203 | 54 | - | 54 | |||
| Stock issued in APT acquisition | - | 1,486,620 | 1 | 2,999 | - | 3,000 | ||
| Stock-based compensation | - | 168,888 | 1 | 2,569 | - | 2,570 | ||
| Components of net loss | - | - | - | - | (6,190) | (6,190) | ||
| Employee stock purchase plan | - | 14,530 | - | 25 | - | - | 25 | |
| Balance at September 30, 2024 | 21,683 | $5,408 | 84,713,400 | $85 | $565,146 | $(206) | $(554,210) | $10,815 |
Three Months Ended September 30, 2025
| (in thousands, except share amounts) · Convertible Preferred Stock Series A (Mezzanine) · Common Stock · Additional Paid-In Capital · Treasury Stock · Accumulated Deficit · Total Stockholders’ Equity (Deficit) | ||||||||
|---|---|---|---|---|---|---|---|---|
| Shares | Amount | Shares | Amount | Amount | Amount | Amount | Amount | |
| Balance at June 30, 2025 | 21,233 | $5,296 | 86,004,864 | $86 | $572,950 | $(206) | $(571,374) | $1,456 |
| Stock issued for the exercise of stock options | - | 12,945 | - | 32 | - | 32 | ||
| Stock-based compensation | - | 121,630 | - | 2,503 | - | 2,503 | ||
| Issuance of common stock through the direct offering and regulatory milestone achievement | - | 4,667,710 | 5 | 8,672 | - | 8,677 | ||
| Components of net loss | - | - | - | (6,463) | (6,463) | |||
| Employee stock purchase plan | - | 16,487 | - | 33 | - | 33 | ||
| Preferred stock conversion | (112) | (28) | 264,803 | - | 28 | - | 28 | |
| Balance at September 30, 2025 | 21,121 | $5,268 | 91,088,439 | $91 | $584,218 | $(206) | $(577,837) | $6,266 |
CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY
Nine Months Ended September 30, 2024
| (in thousands, except share amounts) · Convertible Preferred Stock Series A (Mezzanine) · Common Stock · Additional Paid-In Capital · Treasury Stock · Accumulated Deficit · Total Stockholders’ Equity (Deficit) | ||||||||
|---|---|---|---|---|---|---|---|---|
| Shares | Amount | Shares | Amount | Amount | Amount | Amount | Amount | |
| Balance at December 31, 2023 | 22,358 | $5,577 | 80,949,697 | $81 | $554,148 | $(206) | $(537,680) | $16,343 |
| Stock issued for the exercise of stock options | - | 64,966 | - | 66 | - | 66 | ||
| Stock issued in APT acquisition | - | 1,486,620 | 1 | 2,999 | - | 3,000 | ||
| Stock-based compensation | - | 673,263 | 1 | 7,695 | - | 7,696 | ||
| Components of net loss | - | - | - | - | (16,530) | (16,530) | ||
| Employee stock purchase plan | - | 37,552 | - | 72 | - | 72 | ||
| Preferred stock conversion | (675) | (169) | 1,501,302 | 2 | 166 | - | 168 | |
| Balance at September 30, 2024 | 21,683 | $5,408 | 84,713,400 | $85 | $565,146 | $(206) | $(554,210) | $10,815 |
Nine Months Ended September 30, 2025
| (in thousands, except share amounts) · Convertible Preferred Stock Series A (Mezzanine) · Common Stock · Additional Paid-In Capital · Treasury Stock · Accumulated Deficit · Total Stockholders’ Equity (Deficit) | ||||||||
|---|---|---|---|---|---|---|---|---|
| Shares | Amount | Shares | Amount | Amount | Amount | Amount | Amount | |
| Balance at December 31, 2024 | 21,458 | 5,352 | 85,326,557 | $85 | $567,926 | $(206) | $(561,725) | $6,080 |
| Stock issued for the exercise of stock options | - | 18,548 | - | 35 | - | 35 | ||
| Stock-based compensation | - | 242,538 | - | 7,405 | - | 7,405 | ||
| Issuance of common stock through the direct offering and regulatory milestone achievement | - | 4,667,710 | 5 | 8,672 | - | 8,677 | ||
| Components of net loss | - | - | - | (16,112) | (16,112) | |||
| Employee stock purchase plan | - | 50,228 | - | 96 | - | 96 | ||
| Preferred stock conversion | (337) | (84) | 782,858 | 1 | 84 | - | 85 | |
| Balance at September 30, 2025 | 21,121 | $5,268 | 91,088,439 | $91 | $584,218 | $(206) | $(577,837) | $6,266 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.